Letter by Koh Regarding Article, "Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease".
作者信息
Koh Kwang Kon
机构信息
Department of Cardiovascular Medicine, Heart Center, Gachon University, Gil Medical Center, and Gachon Cardiovascular Research Institute, Incheon, Korea.
出版信息
Circulation. 2018 Aug 21;138(8):846-847. doi: 10.1161/CIRCULATIONAHA.118.033867.
Abstract
摘要
Zotero 插件